Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.80
Bid: 5.55
Ask: 6.10
Change: 0.075 (1.30%)
Spread: 0.55 (9.91%)
Open: 5.85
High: 5.85
Low: 5.80
Prev. Close: 5.75
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Plant Health Care and Wilbur-Ellis sign Agreement

9 Nov 2020 07:00

RNS Number : 5671E
Plant Health Care PLC
09 November 2020
 

 

RNS

 

 

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Plant Health Care® and Wilbur-Ellis® Agribusiness enter into Joint-Development Agreement for PREtec products

 

November 9, 2020 - Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets and Wilbur-Ellis® Agribusiness, a recognized leader in precision agriculture, crop protection, seed, nutrition and biological products, announced today they have entered a strategic collaboration for the development of products selected from Plant Health Care's PREtec peptide portfolio.

 

Plant Health Care's plant response elicitor ("PREtec") peptides represent a novel class of technology that stimulate the plant to defend itself. Derived from natural proteins, PREtec is an environmentally friendly approach to protecting crops and increasing yields and is compatible with mainstream agricultural practice. PREtec peptides promote plant health, suppress disease and soil nematodes and increase yield. PREtec may allow farmers to reduce applications of less safe chemical fungicides and achieve better control of damaging plant diseases.

 

Highlights:

 

- Plant Health Care has been developing PHC279 and other peptides that offer substantial benefits to growers in the U.S.

- Wilbur-Ellis, one of the largest U.S. ag retailers, will use its decades of agriculture knowledge and work with Plant Health Care to develop and launch products using PREtec peptides in the specialty crop market.

- Multiple PREtec products are being evaluated by the two companies.

- The first product launches will occur soon after regulatory approvals have been obtained.

 

Wilbur-Ellis, which has an established track record of bringing novel technologies to U.S. growers of specialty crops (fruits, nuts and vegetables), has been working with PREtec over the last growing season to understand how the technology works and where to best position it in the market. Based on that experience, they wish to accelerate their work with Plant Health Care to bring the benefits of these products to U.S. growers. This is intended to be a long-term collaboration to develop a series of products based on PREtec peptides.

 

Multiple PREtec products are being evaluated, initially focusing on improving disease and nematode control, and stress tolerance. The parties are committed to rapidly moving new products through the development process in order to make this novel technology available to growers as soon as possible. This collaboration brings together the development and marketing strengths, as well as decades of agriculture knowledge of Wilbur-Ellis, especially in biological products, with Plant Health Care's industry-leading expertise on PREtec peptides.

 

Chris Richards, CEO of Plant Health Care, said "We are delighted to be working with Wilbur-Ellis to bring the benefits of PREtec peptides to growers of specialty crops. Wilbur-Ellis has been working with our Employ brand (Harpin αβ) for many years and has significantly increased sales since being appointed exclusive distributor for U.S. specialty crops in 2019. They are the ideal partner for us to work with to develop a series of PREtec products in U.S. specialty crops over the coming years, with the first launch as early as the end of 2022, subject to regulatory approvals. This agreement represents an important validation of the commercial value of PREtec as we move to the first product launches. After more than six years and over $20m invested, the benefits of PREtec peptide products will soon be widely available to growers in the U.S. and elsewhere."

 

"Our mission is to maximize the return on investment for our customers," said Wilbur-Ellis Agribusiness President Mark Ripato. "We're looking at numerous paths to deliver those results. We believe the biologicals segment is one of those. Therefore, we are excited to work with Plant Health Care, a globally recognized innovator in this segment, to help us deliver value to the grower in a sustainable way."

 

# # #

About the Wilbur-Ellis Companies 

Founded in 1921, the Wilbur-Ellis companies are leading international marketers and distributors of agricultural products, animal feed, industrial chemicals, specialty chemicals and ingredients. By developing strong relationships, making strategic market investments and capitalizing on new opportunities, the Wilbur-Ellis companies have continued to grow the business with sales now over $3.4 billion. www.wilburellis.com

Wilbur-Ellis' Agribusiness generates more than $2 billion in sales revenue annually and has 160 branch locations throughout the U.S. www.wilburellisagribusiness.com

About Plant Health Care

Plant Health Care offers products to improve the health, vigor and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favorable environmental profile. Company website: www.planthealthcare.com

 

For further information from Plant Health Care plc, please contact:

Chris Richards, CEO Tel: +1 919 926 1600

Arden Partners plc - Nomad & Broker

John Llewellyn-Lloyd / Ben Cryer Tel: +44 (0) 20 7614 5900

 

For further information from Wilbur-Ellis, please contact:

Katherine Fordon, email: Katherine Fordon, (415) 722-4036.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRZZMGMKVNGGZM
Date   Source Headline
27th Jun 20077:01 amRNSProduct Update
11th Jun 20075:53 pmRNSHolding(s) in Company
8th Jun 20075:03 pmRNSAGM Statement
4th Jun 20077:31 amRNSTotal Voting Rights
17th May 20077:01 amRNSBoard Change
14th May 20077:00 amRNSNotice of AGM
1st May 20073:25 pmRNSTotal Voting Rights
26th Apr 20079:23 amRNSAnnual Report and Accounts
19th Apr 20071:22 pmRNSDirector/PDMR Shareholding
18th Apr 20075:42 pmRNSDirector/PDMR Shareholding
16th Apr 20077:02 amRNSFinal Results
16th Apr 20077:02 amRNSSuccessful Trial Results
30th Mar 20074:54 pmRNSTotal Voting Rights
30th Mar 20074:51 pmRNSHolding(s) in Company
23rd Mar 20076:19 pmRNSHolding(s) in Company
13th Mar 20079:01 amRNSNotice of Results
5th Mar 20075:36 pmRNSExercise of Options
5th Mar 20075:20 pmRNSHolding(s) in Company
5th Mar 20078:04 amRNSHolding(s) in Company
1st Mar 20073:33 pmRNSTotal Voting Rights
1st Mar 20077:04 amRNSRe Acquisition
15th Feb 20079:04 amRNSPartnership
8th Feb 200712:13 pmRNSAdditional Listing
6th Feb 20075:52 pmRNSAdditional Listing
5th Feb 200710:19 amRNSHolding(s) in Company
2nd Feb 20078:40 amRNSHolding(s) in Company
31st Jan 20077:01 amRNSDirector/PDMR Shareholding
24th Jan 200712:01 pmRNSHolding(s) in Company
19th Jan 200712:24 pmRNSTotal Voting Rights
18th Jan 20076:06 pmRNSDirector/PDMR Shareholding
17th Jan 20077:01 amRNSMyconate Agreement
17th Jan 20077:01 amRNSTrading Statement
15th Jan 200710:42 amRNSMyconate Update
5th Jan 20079:01 amRNSExercise of Options
20th Dec 20064:14 pmRNSTotal Voting Rights
4th Dec 20067:00 amRNSAcquisition
14th Nov 20063:59 pmRNSAdditional Listing
13th Nov 20067:01 amRNSSupply Agreement & New Order
24th Oct 200610:52 amRNSHolding(s) in Company
16th Oct 20068:55 amRNSHolding(s) in Company
11th Oct 200610:34 amRNSHolding(s) in Company
29th Sep 200610:04 amRNSInterim Report
27th Sep 20061:43 pmRNSExercise of options
26th Sep 20067:02 amRNSInterim Results
26th Sep 20067:02 amRNSUpdated Myconate Release
13th Sep 20067:01 amRNSNotice of Results
1st Aug 20062:31 pmRNSAdditional Listing
16th Jun 20068:38 amRNSDirector/PDMR Shareholding
9th Jun 200611:31 amRNSAGM Statement
8th Jun 20061:15 pmRNSPress Speculation Re Pre Tect

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.